Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp

Home/All Molecules/Empagliflozin

Empagliflozin Range

Comprehensive Empagliflozin portfolio for Franchise & Manufacturing.

Category
empagliflozin
Total Formulations
14
Available Forms
Tablets
Featured Combinations
Browse by Form
Why Partner with Us?
About Molecule
Franchise FAQ

Expand Your Business with Our Multiple Divisions

General and OTC
Critical Care Injections
Gynae and Infertility care
Respiratory Care
Pediatric Medicines
Derma Care
Neuro care
Eye and Ear care
Ayurvedic Herbal care
Cardiac Diabetic Care
Cardiac Diabetic Care
Cardiac Diabetic Care

Browse Empagliflozin portfolio by Dosage Form

Tablets

The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Empagliflozin batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Empagliflozin Product Range & PCD Franchise

Empagliflozin PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering 14 Empagliflozin formulations for PCD pharma franchise, distributors and monopoly marketing partners across India. The range covers standalone tablets and fixed-dose antidiabetic combinations.

What is Empagliflozin?

Empagliflozin is an oral SGLT2 (sodium-glucose co-transporter-2) inhibitor that lowers blood glucose by increasing urinary glucose excretion. Beyond glycaemic control it has demonstrated cardiovascular and kidney-protective benefits, expanding its use in heart failure and chronic kidney disease. Reference: PubChem.

Available Empagliflozin Formulations

Cafoli Lifecare's Empagliflozin portfolio is available as Tablet, including single-molecule strengths and combinations with metformin and linagliptin.

Therapeutic Applications

Empagliflozin is used for type 2 diabetes mellitus and, based on major outcome trials, for heart failure and chronic kidney disease. It is prescribed by diabetologists, endocrinologists, cardiologists and general physicians, often alongside metformin or DPP-4 inhibitors.

Why Empagliflozin is a High-Potential Molecule for Distributors

SGLT2 inhibitors are among the fastest-growing antidiabetic classes in India, driven by strong cardiovascular and renal evidence and rising type-2-diabetes prevalence. Empagliflozin's chronic, lifelong-therapy profile and premium positioning make it a high-value, high-retention addition to a diabetic-cardiac franchise range.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly (district-wise) distribution rights, WHO-GMP and DCGI-approved manufacturing, attractive net rates, complete promotional inputs (visual aids, MR bags, product cards) and prompt dispatch — trusted by 1000+ franchise partners across India.

References

  1. PubChem – Empagliflozin
  2. PubMed – Empagliflozin literature

Aceclofenac in Modern Clinical Practice

Our formulations of Empagliflozin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:

FAQ about Empagliflozin in PCD Franchise

Start Your Empagliflozin Franchise with Cafoli Lifecare

Partner with Cafoli Lifecare for monopoly-based Empagliflozin PCD pharma franchise. Call +91 95184 47302 or email info@cafoli.in to check availability in your district.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 14 Empagliflozin formulations, including standalone tablets and fixed-dose combinations with metformin and DPP-4 inhibitors such as linagliptin.

Yes. Cafoli Lifecare grants district-wise monopoly rights so partners can market the full Empagliflozin range without internal competition.

Diabetologists, endocrinologists, cardiologists and general physicians prescribe Empagliflozin for type 2 diabetes and, increasingly, for heart failure and chronic kidney disease.

As an SGLT2 inhibitor, Empagliflozin lowers blood glucose while offering proven cardiovascular and renal protection, so it is a fast-growing, premium segment with strong prescribing momentum.

A valid Drug License (DL) and GST registration are required to appoint a Cafoli Lifecare Empagliflozin PCD franchise.

Our Manufacturing Partners

Our Manufacturing Partner | Akums Drugs and Pharmaceuticals
Our Manufacturing Partner | Pharmaceuticals Pvt. Ltd.
Our Manufacturing Partner | Tirupati
Our Manufacturing Partner | Swess-Garniers
Our Manufacturing Partner | Windlas Biotech Limited
Our Manufacturing Partner | Hetero Pharmaceutical company
Our Manufacturing Partner | Unimarck
Our Manufacturing Partner | mascort
Our Manufacturing Partner | Synokem Pharmaceuticals Limited
Our Manufacturing Partner | Biodeal Pharmaceuticals Limited